Dasatinib Inhibits FLT3/ITD and PTPN11mutated Acute Myeloid Leukemia Cells Overexpressing SRC Tyrosine Kinases

被引：0

作者：

Tavor, Sigal ^{[1
]}

Shalit, Tali ^{[2
]}

Ilani, Noa Chapal ^{[3
]}

Moskovitz, Yoni ^{[3
]}

Livnat, Nir ^{[2
]}

Groner, Yoram ^{[2
]}

Bar, Haim ^{[2
]}

Plotnikov, Alexander ^{[2
]}

Kaushansky, Nathali ^{[3
]}

Shlush, Liran I. ^{[3
]}

机构：

[1] Assuta Med Ctr, Hematooncol, Tel Aviv, Israel

[2] Weizmann Inst Sci, Rehovot, Israel

[3] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-128016

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1451

引用

页数：4

共 50 条

[41] Characterization of acute myeloid leukemia with PTPN11 mutation -: The mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD
Hou, Hsin-An
Chou, Wen-Chien
Chen, Chien-Yuan
Lin, Liang-In
Tang, Jih-Luh
Tseng, Mei-Hsuan
Huang, Chi-Fei
Chiou, Rong-Jing
Lee, Fen-Yu
Liu, Ming-Chih
Tien, Hwei-Fang
BLOOD, 2007, 110 (11) : 1022A - 1022A
[42] Combined inhibition of Notch and FLT3 produces synergistic cytotoxic effects in FLT3/ITD+ acute myeloid leukemia
Dan Li
Tongjuan Li
Zhen Shang
Lei Zhao
Qian Xu
Jiaqi Tan
Yun Qin
Yuanyuan Zhang
Yang Cao
Na Wang
Liang Huang
Xiaojian Zhu
Kuangguo Zhou
Liting Chen
Chunrui Li
Ting Xie
Yi Yang
Jue Wang
Jianfeng Zhou
Signal Transduction and Targeted Therapy, 5
[43] Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade
Badar, Talha
Kantarjian, Hagop M.
Nogueras-Gonzalez, Graciela M.
Borthakur, Gautam
Manero, Guillermo Garcia
Andreeff, Michael
Konopleva, Marina
Kadia, Tapan M.
Daver, Naval
Wierda, William G.
Luthra, Raja
Patel, Keyur
Oran, Betul
Champlin, Richard
Ravandi, Farhad
Cortes, Jorge E.
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (11) : 1065 - 1070
[44] Combined inhibition of Notch and FLT3 produces synergistic cytotoxic effects in FLT3/ITD+ acute myeloid leukemia
Li, Dan
Li, Tongjuan
Shang, Zhen
Zhao, Lei
Xu, Qian
Tan, Jiaqi
Qin, Yun
Zhang, Yuanyuan
Cao, Yang
Wang, Na
Huang, Liang
Zhu, Xiaojian
Zhou, Kuangguo
Chen, Liting
Li, Chunrui
Xie, Ting
Yang, Yi
Wang, Jue
Zhou, Jianfeng
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
[45] Incorporation of FLT3 Inhibitors Into the Treatment Regimens for FLT3 Mutated Acute Myeloid Leukemia The Case for Total Therapy
Perl, Alexander E.
Pratz, Keith W.
CANCER JOURNAL, 2022, 28 (01): : 14 - 20
[46] mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells
Chen, Weina
Drakos, Elias
Grammatikakis, Ioannis
Schlette, Ellen J.
Li, Jiang
Leventaki, Vasiliki
Staikou-Drakopoulou, Efi
Patsouris, Efstratios
Panayiotidis, Panayiotis
Medeiros, L. Jeffrey
Rassidakis, George Z.
MOLECULAR CANCER, 2010, 9
[47] mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3- mutated acute myeloid leukemia cells
Weina Chen
Elias Drakos
Ioannis Grammatikakis
Ellen J Schlette
Jiang Li
Vasiliki Leventaki
Efi Staikou-Drakopoulou
Efstratios Patsouris
Panayiotis Panayiotidis
L Jeffrey Medeiros
George Z Rassidakis
Molecular Cancer, 9
[48] PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia
Yamamoto, Tomoko
Isomura, Mariko
Xu, Yinyan
Liang, Juan
Yagasaki, Hiroshi
Kamachi, Yoshiro
Kudo, Kazuko
Kiyoi, Hitoshi
Naoe, Tomoki
Kojma, Seiji
LEUKEMIA RESEARCH, 2006, 30 (09) : 1085 - 1089
[49] Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia
Koo, Bon-Kwan
Choi, Eun-Ji
Moon, Ju Hyun
Kim, Ji Yun
Park, Hyunkyung
Park, Han-Seung
Choi, Yunsuk
Lee, Jung-Hee
Lee, Kyoo-Hyung
Choi, Eun Kyung
Kim, Eunji
Lee, Je-Hwan
Hur, Eun-Hye
BLOOD CANCER JOURNAL, 2024, 14 (01):
[50] Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
Dan Xu
Yishan Chen
Ying Yang
Zhao Yin
Changfen Huang
Qiang Wang
Ling Jiang
Xuejie Jiang
Changxin Yin
Qifa Liu
Guopan Yu
Journal of Translational Medicine, 20

← 1 2 3 4 5 →